Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Expert: Drug Makers 'Need to In-License Now' => Rx Investors.com

|Includes:Amgen Inc. (AMGN), AZN, BAYRY, BMY, CELG, DSKYY, GSK, JNJ, LLY, MRK, NVS, PFE, RHHBY, SNY, TKPHF

CANCER DRUGS

Just posted this morning at
Rx Investors:



Why Subscribe to Rx Investors:
  • Consistency
  • In-Depth Research
  • Know-How
  • Objective Opinion
  • Persistence
  • Clear & Concise Buy / Sell Recommendations 
  • Excellent Results: 42 out of 52 (81%) Buy Recommendations have been closed with a profit since March 12, 2010.

Succeed.  Subscribe Today!

Annual Premium PLUS Subscription $200

Annual Premium Subscription: $75

 


Disclosure: No positions.